Glenmark’s US Arm to Launch Sodium Phosphate Injection; Distribution to Begin in April
Glenmark Pharmaceuticals Ltd. has announced that its wholly owned subsidiary, Glenmark Pharmaceuticals Inc., USA, will launch Sodium Phosphate Injection in […]
Glenmark Pharmaceuticals Ltd. has announced that its wholly owned subsidiary, Glenmark Pharmaceuticals Inc., USA, will launch Sodium Phosphate Injection in […]
Glenmark Specialty SA, a pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) to sell a […]
Glenmark Specialty S.A. (Glenmark), a subsidiary of the globally renowned Glenmark Pharmaceuticals Ltd., has entered into an exclusive marketing and […]
Glenmark Pharmaceuticals Ltd., a global leader in pharmaceuticals, has launched the next phase of their impactful ‘India First Heart First’ […]
Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market, as […]
Pharma major Glenmark Pharmaceuticals has chalked out a $300 million capital expenditure plan for the next three years to fund […]